Literature DB >> 16924176

Multimodality imaging for vertebral metastases in a rat osteolytic model.

Shane Burch1, Stuart K Bisland, Brian C Wilson, Cari Whyne, Albert J M Yee.   

Abstract

Imaging modalities facilitate the detection of early bony metastases. Few studies specifically address vertebral metastases in animal models for preclinical (early, asymptomatic) disease. We performed intracardiac injection of human breast cancer (MT-1) cells in 35 athymic nude rats. We evaluated potential temporal differences in appendicular versus axial metastases as detectable by longitudinal in vivo conventional radiography (ie, fine detail radiography and two-dimensional fluoroscopy). We compared bioluminescent reporter imaging with conventional radiographs in the detection of vertebral metastasis, and compared bioluminescent imaging with subsequent ex vivo microcomputed tomography analysis of osteolysis. The mean survival was 25 days in the animals that had metastases develop. Conventional radiographs identified appendicular osteolysis by 14 days; however, vertebral osteolysis was identified late in the metastatic spread (Days 25-28). Bioluminescence imaging was more sensitive in earlier detection of vertebral lesions in all imaged animals at Day 21, which corresponded to microcomputed tomography evaluation of osteolysis. Conventional radiographs do not appear useful for early detection of vertebral metastasis. Early identification of metastasis is important when considering the use of this model to evaluate therapeutic outcomes directed toward vertebral metastasis.

Entities:  

Mesh:

Year:  2007        PMID: 16924176     DOI: 10.1097/01.blo.0000238787.44349.eb

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  7 in total

1.  In vivo fluorescence imaging of the reticuloendothelial system using quantum dots in combination with bioluminescent tumour monitoring.

Authors:  Yusuke Inoue; Kiyoko Izawa; Kohki Yoshikawa; Haruyasu Yamada; Arinobu Tojo; Kuni Ohtomo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-21       Impact factor: 9.236

2.  Combined micro CT and histopathology for evaluation of skeletal metastasis in live animals.

Authors:  Christopher P Geffre; Erika Pond; Gerald D Pond; Isis C Sroka; Jaime M Gard; Bethany A Skovan; William E Meek; Terry H Landowski; Raymond B Nagle; Anne E Cress
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

3.  An in vivo mouse model of intraosseous spinal cancer causing evolving paraplegia.

Authors:  Davina A F Cossigny; Effie Mouhtouris; Sathana Dushyanthen; Augusto Gonzalvo; Gerald M Y Quan
Journal:  J Neurooncol       Date:  2013-08-18       Impact factor: 4.130

4.  Metastatic human breast cancer to the spine produces mechanical hyperalgesia and gait deficits in rodents.

Authors:  Rachel Sarabia-Estrada; Alejandro Ruiz-Valls; Hugo Guerrero-Cazares; Ana M Ampuero; Ismael Jimenez-Estrada; Samantha De Silva; Lydia J Bernhardt; Courtney Rory Goodwin; Ali Karim Ahmed; Yuxin Li; Neil A Phillips; Ziya L Gokaslan; Alfredo Quiñones-Hinojosa; Daniel M Sciubba
Journal:  Spine J       Date:  2017-04-13       Impact factor: 4.166

5.  Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation.

Authors:  Ho-Taek Song; Elaine K Jordan; Bobbi K Lewis; Wei Liu; Justin Ganjei; Brenda Klaunberg; Daryl Despres; Diane Palmieri; Joseph A Frank
Journal:  J Transl Med       Date:  2009-10-20       Impact factor: 5.531

6.  Treatment of canine osseous tumors with photodynamic therapy: a pilot study.

Authors:  S Burch; C London; B Seguin; C Rodriguez; B C Wilson; S K Bisland
Journal:  Clin Orthop Relat Res       Date:  2009-01-22       Impact factor: 4.176

7.  The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.

Authors:  Albert J M Yee; Margarete Akens; Bing L Yang; Joel Finkelstein; Peng-Sheng Zheng; Zhaoqiong Deng; Burton Yang
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.